Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Copper(I)-mediated 11C-carboxylation of (hetero)arylstannanes: radiosynthesis of [11C]bexarotene.

Ian Duffy, Kenneth Dahl and Neil Vasdev
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 137;
Ian Duffy
1Centre for Addiction and Mental Health Toronto ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Dahl
1Centre for Addiction and Mental Health Toronto ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Vasdev
1Centre for Addiction and Mental Health Toronto ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 137

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Ian Duffy1,
  2. Kenneth Dahl1 and
  3. Neil Vasdev1
  1. 1Centre for Addiction and Mental Health Toronto ON Canada

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20204800
Jun 20204300
Jul 20201800
Aug 20201100
Sep 2020400
Oct 2020800
Nov 2020700
Dec 2020800
Jan 2021600
Feb 20211300
Mar 20211300
Apr 20211600
May 20211600
Jun 20211000
Jul 20211000
Aug 2021800
Sep 2021200
Oct 2021700
Nov 2021900
Dec 2021600
Jan 2022300
Feb 2022600
Mar 2022400
Apr 2022800
May 2022200
Jun 2022400
Jul 2022100
Aug 2022100
Sep 2022100
Oct 2022400
Nov 2022200
Dec 2022200
Jan 2023300
Feb 2023300
Mar 2023300
Apr 2023500
May 2023100
Jun 2023500
Jul 2023300
Aug 2023400
Sep 2023300
Oct 2023600
Nov 2023400
Dec 2023300
Jan 2024300
Feb 2024300
Mar 2024100
Apr 2024400
May 2024500
Jun 2024100
Jul 2024100
Aug 20241200
Sep 20241200
Oct 2024300
Nov 2024800
Dec 2024100
Jan 2025400
Feb 2025600
Mar 2025300
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Copper(I)-mediated 11C-carboxylation of (hetero)arylstannanes: radiosynthesis of [11C]bexarotene.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Copper(I)-mediated 11C-carboxylation of (hetero)arylstannanes: radiosynthesis of [11C]bexarotene.
Ian Duffy, Kenneth Dahl, Neil Vasdev
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 137;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Copper(I)-mediated 11C-carboxylation of (hetero)arylstannanes: radiosynthesis of [11C]bexarotene.
Ian Duffy, Kenneth Dahl, Neil Vasdev
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 137;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Predictive modeling of tau aggregation and propagation using PET and DTI
  • Design of calcium-sensing receptor targeted thera(g)nostic agents
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Radiopharmaceutical Sciences (RPSC) YIA Symposium

  • Delta-like Ligand 3 (DLL3) is a novel target for molecular imaging of Neuroendocrine Prostate Cancer
  • Direct Aromatic 18F-labeling of Tetrazines: A Rapid and Convenient Entry to Tetrazines for Pretargeted PET Imaging
Show more Radiopharmaceutical Sciences (RPSC) YIA Symposium

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire